nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—Lisinopril—systemic scleroderma	0.124	0.228	CbGbCtD
Fesoterodine—ABCB1—Captopril—systemic scleroderma	0.0925	0.171	CbGbCtD
Fesoterodine—CYP2D6—Captopril—systemic scleroderma	0.0872	0.161	CbGbCtD
Fesoterodine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0729	0.134	CbGbCtD
Fesoterodine—ABCB1—Prednisone—systemic scleroderma	0.0582	0.107	CbGbCtD
Fesoterodine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0437	0.0805	CbGbCtD
Fesoterodine—CYP3A4—Prednisone—systemic scleroderma	0.0349	0.0644	CbGbCtD
Fesoterodine—ABCB1—Methotrexate—systemic scleroderma	0.0292	0.0539	CbGbCtD
Fesoterodine—Angioedema—Leflunomide—systemic scleroderma	0.00109	0.00238	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00238	CcSEcCtD
Fesoterodine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00107	0.00235	CcSEcCtD
Fesoterodine—Vertigo—Leflunomide—systemic scleroderma	0.00107	0.00234	CcSEcCtD
Fesoterodine—Insomnia—Captopril—systemic scleroderma	0.00107	0.00234	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00107	0.00234	CcSEcCtD
Fesoterodine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00107	0.00233	CcSEcCtD
Fesoterodine—Abdominal pain—Mometasone—systemic scleroderma	0.00106	0.00233	CcSEcCtD
Fesoterodine—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00106	0.00232	CcSEcCtD
Fesoterodine—Palpitations—Leflunomide—systemic scleroderma	0.00106	0.00231	CcSEcCtD
Fesoterodine—Somnolence—Captopril—systemic scleroderma	0.00105	0.0023	CcSEcCtD
Fesoterodine—Cough—Leflunomide—systemic scleroderma	0.00104	0.00228	CcSEcCtD
Fesoterodine—Dyspepsia—Captopril—systemic scleroderma	0.00104	0.00227	CcSEcCtD
Fesoterodine—Mental disorder—Lisinopril—systemic scleroderma	0.00103	0.00226	CcSEcCtD
Fesoterodine—Dizziness—Pentoxifylline—systemic scleroderma	0.00103	0.00225	CcSEcCtD
Fesoterodine—Infection—Azathioprine—systemic scleroderma	0.00103	0.00224	CcSEcCtD
Fesoterodine—Vertigo—Mycophenolic acid—systemic scleroderma	0.00102	0.00224	CcSEcCtD
Fesoterodine—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00223	CcSEcCtD
Fesoterodine—Fatigue—Captopril—systemic scleroderma	0.00102	0.00223	CcSEcCtD
Fesoterodine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00222	CcSEcCtD
Fesoterodine—Chest pain—Leflunomide—systemic scleroderma	0.00102	0.00222	CcSEcCtD
Fesoterodine—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00221	CcSEcCtD
Fesoterodine—Constipation—Captopril—systemic scleroderma	0.00101	0.00221	CcSEcCtD
Fesoterodine—Flatulence—Lisinopril—systemic scleroderma	0.00101	0.00221	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00101	0.00221	CcSEcCtD
Fesoterodine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00101	0.0022	CcSEcCtD
Fesoterodine—Dysgeusia—Lisinopril—systemic scleroderma	0.00101	0.0022	CcSEcCtD
Fesoterodine—Skin disorder—Azathioprine—systemic scleroderma	0.001	0.00219	CcSEcCtD
Fesoterodine—Dry mouth—Leflunomide—systemic scleroderma	0.000995	0.00217	CcSEcCtD
Fesoterodine—Cough—Mycophenolic acid—systemic scleroderma	0.000994	0.00217	CcSEcCtD
Fesoterodine—Back pain—Lisinopril—systemic scleroderma	0.000993	0.00217	CcSEcCtD
Fesoterodine—Rash—Pentoxifylline—systemic scleroderma	0.000984	0.00215	CcSEcCtD
Fesoterodine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000983	0.00215	CcSEcCtD
Fesoterodine—Headache—Pentoxifylline—systemic scleroderma	0.000978	0.00214	CcSEcCtD
Fesoterodine—Face oedema—Prednisone—systemic scleroderma	0.000977	0.00213	CcSEcCtD
Fesoterodine—Feeling abnormal—Captopril—systemic scleroderma	0.000975	0.00213	CcSEcCtD
Fesoterodine—Chest pain—Mycophenolic acid—systemic scleroderma	0.00097	0.00212	CcSEcCtD
Fesoterodine—Infection—Leflunomide—systemic scleroderma	0.000968	0.00212	CcSEcCtD
Fesoterodine—Vision blurred—Lisinopril—systemic scleroderma	0.000967	0.00211	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000967	0.00211	CcSEcCtD
Fesoterodine—Asthenia—Mometasone—systemic scleroderma	0.000966	0.00211	CcSEcCtD
Fesoterodine—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000965	0.00211	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000963	0.0021	CcSEcCtD
Fesoterodine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000959	0.00209	CcSEcCtD
Fesoterodine—Nervous system disorder—Leflunomide—systemic scleroderma	0.000956	0.00209	CcSEcCtD
Fesoterodine—Pruritus—Mometasone—systemic scleroderma	0.000953	0.00208	CcSEcCtD
Fesoterodine—Tachycardia—Leflunomide—systemic scleroderma	0.000951	0.00208	CcSEcCtD
Fesoterodine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000949	0.00207	CcSEcCtD
Fesoterodine—Skin disorder—Leflunomide—systemic scleroderma	0.000947	0.00207	CcSEcCtD
Fesoterodine—Angioedema—Lisinopril—systemic scleroderma	0.000938	0.00205	CcSEcCtD
Fesoterodine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000938	0.00205	CcSEcCtD
Fesoterodine—Abdominal pain—Captopril—systemic scleroderma	0.000935	0.00204	CcSEcCtD
Fesoterodine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000931	0.00203	CcSEcCtD
Fesoterodine—Dry skin—Prednisone—systemic scleroderma	0.000928	0.00203	CcSEcCtD
Fesoterodine—Nausea—Pentoxifylline—systemic scleroderma	0.000927	0.00202	CcSEcCtD
Fesoterodine—Infection—Mycophenolic acid—systemic scleroderma	0.000924	0.00202	CcSEcCtD
Fesoterodine—Vertigo—Lisinopril—systemic scleroderma	0.000922	0.00201	CcSEcCtD
Fesoterodine—Diarrhoea—Mometasone—systemic scleroderma	0.000921	0.00201	CcSEcCtD
Fesoterodine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000912	0.00199	CcSEcCtD
Fesoterodine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000908	0.00198	CcSEcCtD
Fesoterodine—Palpitations—Lisinopril—systemic scleroderma	0.000907	0.00198	CcSEcCtD
Fesoterodine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000905	0.00198	CcSEcCtD
Fesoterodine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000903	0.00197	CcSEcCtD
Fesoterodine—Cough—Lisinopril—systemic scleroderma	0.000896	0.00196	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000893	0.00195	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000891	0.00195	CcSEcCtD
Fesoterodine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000886	0.00194	CcSEcCtD
Fesoterodine—Insomnia—Leflunomide—systemic scleroderma	0.000882	0.00193	CcSEcCtD
Fesoterodine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000881	0.00192	CcSEcCtD
Fesoterodine—Chest pain—Lisinopril—systemic scleroderma	0.000874	0.00191	CcSEcCtD
Fesoterodine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00087	0.0019	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000868	0.0019	CcSEcCtD
Fesoterodine—Dyspepsia—Leflunomide—systemic scleroderma	0.000858	0.00187	CcSEcCtD
Fesoterodine—Dry mouth—Lisinopril—systemic scleroderma	0.000855	0.00187	CcSEcCtD
Fesoterodine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000851	0.00186	CcSEcCtD
Fesoterodine—Rash—Mometasone—systemic scleroderma	0.000849	0.00185	CcSEcCtD
Fesoterodine—Asthenia—Captopril—systemic scleroderma	0.000849	0.00185	CcSEcCtD
Fesoterodine—Dermatitis—Mometasone—systemic scleroderma	0.000848	0.00185	CcSEcCtD
Fesoterodine—Confusional state—Lisinopril—systemic scleroderma	0.000845	0.00184	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000844	0.00184	CcSEcCtD
Fesoterodine—Headache—Mometasone—systemic scleroderma	0.000844	0.00184	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000842	0.00184	CcSEcCtD
Fesoterodine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000841	0.00184	CcSEcCtD
Fesoterodine—Fatigue—Leflunomide—systemic scleroderma	0.00084	0.00184	CcSEcCtD
Fesoterodine—Pruritus—Captopril—systemic scleroderma	0.000837	0.00183	CcSEcCtD
Fesoterodine—Constipation—Leflunomide—systemic scleroderma	0.000834	0.00182	CcSEcCtD
Fesoterodine—Infection—Lisinopril—systemic scleroderma	0.000832	0.00182	CcSEcCtD
Fesoterodine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000827	0.00181	CcSEcCtD
Fesoterodine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000822	0.00179	CcSEcCtD
Fesoterodine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000819	0.00179	CcSEcCtD
Fesoterodine—Tachycardia—Lisinopril—systemic scleroderma	0.000817	0.00179	CcSEcCtD
Fesoterodine—Abdominal pain—Azathioprine—systemic scleroderma	0.000816	0.00178	CcSEcCtD
Fesoterodine—Skin disorder—Lisinopril—systemic scleroderma	0.000814	0.00178	CcSEcCtD
Fesoterodine—Diarrhoea—Captopril—systemic scleroderma	0.000809	0.00177	CcSEcCtD
Fesoterodine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000808	0.00176	CcSEcCtD
Fesoterodine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000803	0.00175	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000803	0.00175	CcSEcCtD
Fesoterodine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000802	0.00175	CcSEcCtD
Fesoterodine—Nausea—Mometasone—systemic scleroderma	0.0008	0.00175	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000797	0.00174	CcSEcCtD
Fesoterodine—Constipation—Mycophenolic acid—systemic scleroderma	0.000795	0.00174	CcSEcCtD
Fesoterodine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000795	0.00174	CcSEcCtD
Fesoterodine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000785	0.00171	CcSEcCtD
Fesoterodine—Dizziness—Captopril—systemic scleroderma	0.000782	0.00171	CcSEcCtD
Fesoterodine—Urticaria—Leflunomide—systemic scleroderma	0.000774	0.00169	CcSEcCtD
Fesoterodine—Abdominal pain—Leflunomide—systemic scleroderma	0.000771	0.00168	CcSEcCtD
Fesoterodine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000766	0.00167	CcSEcCtD
Fesoterodine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000766	0.00167	CcSEcCtD
Fesoterodine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000761	0.00166	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00076	0.00166	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00076	0.00166	CcSEcCtD
Fesoterodine—Insomnia—Lisinopril—systemic scleroderma	0.000758	0.00165	CcSEcCtD
Fesoterodine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000749	0.00164	CcSEcCtD
Fesoterodine—Rash—Captopril—systemic scleroderma	0.000746	0.00163	CcSEcCtD
Fesoterodine—Dermatitis—Captopril—systemic scleroderma	0.000745	0.00163	CcSEcCtD
Fesoterodine—Somnolence—Lisinopril—systemic scleroderma	0.000745	0.00163	CcSEcCtD
Fesoterodine—Headache—Captopril—systemic scleroderma	0.000741	0.00162	CcSEcCtD
Fesoterodine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00162	CcSEcCtD
Fesoterodine—Dyspepsia—Lisinopril—systemic scleroderma	0.000737	0.00161	CcSEcCtD
Fesoterodine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000735	0.00161	CcSEcCtD
Fesoterodine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000729	0.00159	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000723	0.00158	CcSEcCtD
Fesoterodine—Fatigue—Lisinopril—systemic scleroderma	0.000722	0.00158	CcSEcCtD
Fesoterodine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00072	0.00157	CcSEcCtD
Fesoterodine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000718	0.00157	CcSEcCtD
Fesoterodine—Constipation—Lisinopril—systemic scleroderma	0.000716	0.00156	CcSEcCtD
Fesoterodine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000716	0.00156	CcSEcCtD
Fesoterodine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000713	0.00156	CcSEcCtD
Fesoterodine—Diarrhoea—Azathioprine—systemic scleroderma	0.000706	0.00154	CcSEcCtD
Fesoterodine—Nausea—Captopril—systemic scleroderma	0.000703	0.00153	CcSEcCtD
Fesoterodine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000701	0.00153	CcSEcCtD
Fesoterodine—Asthenia—Leflunomide—systemic scleroderma	0.000699	0.00153	CcSEcCtD
Fesoterodine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00069	0.00151	CcSEcCtD
Fesoterodine—Pruritus—Leflunomide—systemic scleroderma	0.00069	0.00151	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000685	0.0015	CcSEcCtD
Fesoterodine—Dysuria—Methotrexate—systemic scleroderma	0.000684	0.00149	CcSEcCtD
Fesoterodine—Dizziness—Azathioprine—systemic scleroderma	0.000683	0.00149	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000679	0.00148	CcSEcCtD
Fesoterodine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000667	0.00146	CcSEcCtD
Fesoterodine—Diarrhoea—Leflunomide—systemic scleroderma	0.000667	0.00146	CcSEcCtD
Fesoterodine—Urticaria—Lisinopril—systemic scleroderma	0.000665	0.00145	CcSEcCtD
Fesoterodine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000664	0.00145	CcSEcCtD
Fesoterodine—Abdominal pain—Lisinopril—systemic scleroderma	0.000662	0.00145	CcSEcCtD
Fesoterodine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000658	0.00144	CcSEcCtD
Fesoterodine—Eye disorder—Prednisone—systemic scleroderma	0.000654	0.00143	CcSEcCtD
Fesoterodine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000652	0.00143	CcSEcCtD
Fesoterodine—Infestation NOS—Methotrexate—systemic scleroderma	0.000652	0.00142	CcSEcCtD
Fesoterodine—Infestation—Methotrexate—systemic scleroderma	0.000652	0.00142	CcSEcCtD
Fesoterodine—Rash—Azathioprine—systemic scleroderma	0.000651	0.00142	CcSEcCtD
Fesoterodine—Dermatitis—Azathioprine—systemic scleroderma	0.00065	0.00142	CcSEcCtD
Fesoterodine—Headache—Azathioprine—systemic scleroderma	0.000647	0.00141	CcSEcCtD
Fesoterodine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000646	0.00141	CcSEcCtD
Fesoterodine—Dizziness—Leflunomide—systemic scleroderma	0.000645	0.00141	CcSEcCtD
Fesoterodine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000636	0.00139	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000634	0.00138	CcSEcCtD
Fesoterodine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000628	0.00137	CcSEcCtD
Fesoterodine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000617	0.00135	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000617	0.00135	CcSEcCtD
Fesoterodine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000615	0.00134	CcSEcCtD
Fesoterodine—Rash—Leflunomide—systemic scleroderma	0.000615	0.00134	CcSEcCtD
Fesoterodine—Dermatitis—Leflunomide—systemic scleroderma	0.000614	0.00134	CcSEcCtD
Fesoterodine—Mental disorder—Prednisone—systemic scleroderma	0.000613	0.00134	CcSEcCtD
Fesoterodine—Nausea—Azathioprine—systemic scleroderma	0.000613	0.00134	CcSEcCtD
Fesoterodine—Headache—Leflunomide—systemic scleroderma	0.000611	0.00133	CcSEcCtD
Fesoterodine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000605	0.00132	CcSEcCtD
Fesoterodine—Asthenia—Lisinopril—systemic scleroderma	0.000601	0.00131	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.0006	0.00131	CcSEcCtD
Fesoterodine—Pruritus—Lisinopril—systemic scleroderma	0.000593	0.00129	CcSEcCtD
Fesoterodine—Rash—Mycophenolic acid—systemic scleroderma	0.000586	0.00128	CcSEcCtD
Fesoterodine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000586	0.00128	CcSEcCtD
Fesoterodine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000583	0.00127	CcSEcCtD
Fesoterodine—Headache—Mycophenolic acid—systemic scleroderma	0.000583	0.00127	CcSEcCtD
Fesoterodine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00058	0.00127	CcSEcCtD
Fesoterodine—Nausea—Leflunomide—systemic scleroderma	0.000579	0.00126	CcSEcCtD
Fesoterodine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000578	0.00126	CcSEcCtD
Fesoterodine—Vision blurred—Prednisone—systemic scleroderma	0.000574	0.00125	CcSEcCtD
Fesoterodine—Urethral disorder—Methotrexate—systemic scleroderma	0.000574	0.00125	CcSEcCtD
Fesoterodine—Diarrhoea—Lisinopril—systemic scleroderma	0.000573	0.00125	CcSEcCtD
Fesoterodine—Angioedema—Prednisone—systemic scleroderma	0.000557	0.00122	CcSEcCtD
Fesoterodine—Dizziness—Lisinopril—systemic scleroderma	0.000554	0.00121	CcSEcCtD
Fesoterodine—Nausea—Mycophenolic acid—systemic scleroderma	0.000552	0.00121	CcSEcCtD
Fesoterodine—Vertigo—Prednisone—systemic scleroderma	0.000548	0.0012	CcSEcCtD
Fesoterodine—Eye disorder—Methotrexate—systemic scleroderma	0.000547	0.00119	CcSEcCtD
Fesoterodine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000543	0.00119	CcSEcCtD
Fesoterodine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000541	0.00118	CcSEcCtD
Fesoterodine—Rash—Lisinopril—systemic scleroderma	0.000528	0.00115	CcSEcCtD
Fesoterodine—Dermatitis—Lisinopril—systemic scleroderma	0.000528	0.00115	CcSEcCtD
Fesoterodine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000527	0.00115	CcSEcCtD
Fesoterodine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000527	0.00115	CcSEcCtD
Fesoterodine—Headache—Lisinopril—systemic scleroderma	0.000525	0.00115	CcSEcCtD
Fesoterodine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000519	0.00113	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000515	0.00113	CcSEcCtD
Fesoterodine—Mental disorder—Methotrexate—systemic scleroderma	0.000513	0.00112	CcSEcCtD
Fesoterodine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000502	0.0011	CcSEcCtD
Fesoterodine—Dysgeusia—Methotrexate—systemic scleroderma	0.000499	0.00109	CcSEcCtD
Fesoterodine—Nausea—Lisinopril—systemic scleroderma	0.000498	0.00109	CcSEcCtD
Fesoterodine—Infection—Prednisone—systemic scleroderma	0.000494	0.00108	CcSEcCtD
Fesoterodine—Back pain—Methotrexate—systemic scleroderma	0.000493	0.00108	CcSEcCtD
Fesoterodine—Nervous system disorder—Prednisone—systemic scleroderma	0.000488	0.00107	CcSEcCtD
Fesoterodine—Tachycardia—Prednisone—systemic scleroderma	0.000486	0.00106	CcSEcCtD
Fesoterodine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000485	0.00106	CcSEcCtD
Fesoterodine—Skin disorder—Prednisone—systemic scleroderma	0.000483	0.00106	CcSEcCtD
Fesoterodine—Vision blurred—Methotrexate—systemic scleroderma	0.00048	0.00105	CcSEcCtD
Fesoterodine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000463	0.00101	CcSEcCtD
Fesoterodine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000462	0.00101	CcSEcCtD
Fesoterodine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00046	0.001	CcSEcCtD
Fesoterodine—Vertigo—Methotrexate—systemic scleroderma	0.000458	0.001	CcSEcCtD
Fesoterodine—Insomnia—Prednisone—systemic scleroderma	0.00045	0.000983	CcSEcCtD
Fesoterodine—Cough—Methotrexate—systemic scleroderma	0.000445	0.000971	CcSEcCtD
Fesoterodine—Dyspepsia—Prednisone—systemic scleroderma	0.000438	0.000956	CcSEcCtD
Fesoterodine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000436	0.000952	CcSEcCtD
Fesoterodine—Chest pain—Methotrexate—systemic scleroderma	0.000434	0.000947	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000431	0.000941	CcSEcCtD
Fesoterodine—Fatigue—Prednisone—systemic scleroderma	0.000429	0.000937	CcSEcCtD
Fesoterodine—Constipation—Prednisone—systemic scleroderma	0.000425	0.000929	CcSEcCtD
Fesoterodine—Confusional state—Methotrexate—systemic scleroderma	0.000419	0.000916	CcSEcCtD
Fesoterodine—Infection—Methotrexate—systemic scleroderma	0.000413	0.000902	CcSEcCtD
Fesoterodine—Feeling abnormal—Prednisone—systemic scleroderma	0.00041	0.000895	CcSEcCtD
Fesoterodine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000408	0.000891	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000407	0.000888	CcSEcCtD
Fesoterodine—Skin disorder—Methotrexate—systemic scleroderma	0.000404	0.000882	CcSEcCtD
Fesoterodine—Urticaria—Prednisone—systemic scleroderma	0.000395	0.000863	CcSEcCtD
Fesoterodine—Abdominal pain—Prednisone—systemic scleroderma	0.000393	0.000859	CcSEcCtD
Fesoterodine—Insomnia—Methotrexate—systemic scleroderma	0.000376	0.000821	CcSEcCtD
Fesoterodine—Somnolence—Methotrexate—systemic scleroderma	0.00037	0.000807	CcSEcCtD
Fesoterodine—Hypersensitivity—Prednisone—systemic scleroderma	0.000367	0.000801	CcSEcCtD
Fesoterodine—Dyspepsia—Methotrexate—systemic scleroderma	0.000366	0.000799	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000359	0.000784	CcSEcCtD
Fesoterodine—Fatigue—Methotrexate—systemic scleroderma	0.000358	0.000783	CcSEcCtD
Fesoterodine—Asthenia—Prednisone—systemic scleroderma	0.000357	0.00078	CcSEcCtD
Fesoterodine—Pruritus—Prednisone—systemic scleroderma	0.000352	0.000769	CcSEcCtD
Fesoterodine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000343	0.000748	CcSEcCtD
Fesoterodine—Diarrhoea—Prednisone—systemic scleroderma	0.00034	0.000743	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00034	0.000743	CcSEcCtD
Fesoterodine—Urticaria—Methotrexate—systemic scleroderma	0.00033	0.000721	CcSEcCtD
Fesoterodine—Dizziness—Prednisone—systemic scleroderma	0.000329	0.000719	CcSEcCtD
Fesoterodine—Abdominal pain—Methotrexate—systemic scleroderma	0.000329	0.000718	CcSEcCtD
Fesoterodine—Rash—Prednisone—systemic scleroderma	0.000314	0.000685	CcSEcCtD
Fesoterodine—Dermatitis—Prednisone—systemic scleroderma	0.000313	0.000684	CcSEcCtD
Fesoterodine—Headache—Prednisone—systemic scleroderma	0.000312	0.000681	CcSEcCtD
Fesoterodine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000306	0.000669	CcSEcCtD
Fesoterodine—Asthenia—Methotrexate—systemic scleroderma	0.000298	0.000652	CcSEcCtD
Fesoterodine—Nausea—Prednisone—systemic scleroderma	0.000295	0.000645	CcSEcCtD
Fesoterodine—Pruritus—Methotrexate—systemic scleroderma	0.000294	0.000642	CcSEcCtD
Fesoterodine—Diarrhoea—Methotrexate—systemic scleroderma	0.000284	0.000621	CcSEcCtD
Fesoterodine—Dizziness—Methotrexate—systemic scleroderma	0.000275	0.0006	CcSEcCtD
Fesoterodine—Rash—Methotrexate—systemic scleroderma	0.000262	0.000573	CcSEcCtD
Fesoterodine—Dermatitis—Methotrexate—systemic scleroderma	0.000262	0.000572	CcSEcCtD
Fesoterodine—Headache—Methotrexate—systemic scleroderma	0.00026	0.000569	CcSEcCtD
Fesoterodine—Nausea—Methotrexate—systemic scleroderma	0.000247	0.000539	CcSEcCtD
